| Short Description : | PAX2 Blocking Peptide for STJ502125 is synthetically produced from the 1-50 sequence and is suitable for use in western blot applications. |
| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: | PAX2 |
| Gene ID: | 5076 |
| Uniprot ID: | PAX2_HUMAN |
| Immunogen: | Synthetic peptide taken within amino acid region 1-50 on human PAX2 protein. |
| Immunogen Region: | 1-50 |
| Specificity: | This blocking peptide is recommended for use in combination with PAX2 antibody, STJ502125 |
| Tissue Specificity | Expressed in primitive cells of the kidney, ureter, eye, ear and central nervous system. |
| Function | Transcription factor that may have a role in kidney cell differentiation. Has a critical role in the development of the urogenital tract, the eyes, and the CNS. |
| Peptide Name | Paired Box Protein Pax-2 |
| Database Links | Reactome: R-HSA-9761174Reactome: R-HSA-9830364Reactome: R-HSA-9830674 |
| Cellular Localisation | Nucleus |
| Alternative Peptide Names | Paired Box Protein Pax-2 proteinPAX2 protein |
Information sourced from Uniprot.org